Home/Pipeline/KX-826

KX-826

Androgenetic Alopecia (AGA)

Phase 3Primary endpoint met

Key Facts

Indication
Androgenetic Alopecia (AGA)
Phase
Phase 3
Status
Primary endpoint met
Company

About Kintor Pharma

Chinese biotech developing androgen receptor-targeted therapies for dermatology and oncology with multiple clinical-stage assets.

View full company profile

Therapeutic Areas